Major Players in the Topical Drug Delivery Market are Focusing on Product Launches and Approvals as their Key Growth Strategy

The overall Topical Drug Delivery Market is expected to grow from USD 92.40 billion in 2016 to USD 125.88 billion by 2021, at a CAGR of 6.40% from 2016 to 2021. 

Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. Topical drug delivery is a method of drug administration in the body through ophthalmic, rectal, vaginal, and skin as topical routes to achieve its therapeutic effect. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Galderma S.A. (Switzerland), GlaxoSmithKline plc (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), and Cipla (India) are the prominent players operating in the topical drug delivery market.

GlaxoSmithKline (GSK) plc is the leading player in this market. The company offers products for various dermatological conditions, such as acne, dermatoses, fungal infections, atopic dermatitis, psoriasis, superficial skin infections, and non-melanoma skin cancer. The company primarily focuses on inorganic growth strategies to strengthen its position in the market. For instance, in 2009, GSK acquired Stiefel Laboratories Inc. (U.S.), a dermatological pharmaceutical company, for USD 2.9 billion. Through this acquisition, GSK combined its existing dermatological products with Stiefel’s products.

Read More Details | Get the Sample Pages@ 

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=124871717

Novartis AG is the next leading player in the topical drug delivery market. The company manufactures healthcare and pharmaceutical products. It operates in three segments, namely, Pharmaceuticals, Alcon (Eye Care), and Sandoz (Generics). The company has a broad range of access-to-medicine programs which include drug donations, selling at cost, social business initiatives, and patient assistance programs. In order to maintain its position, the company invests in R&D activities which help it to develop and launch new and advanced products. In 2015, the company invested 18.1% of its total revenue on R&D activities, as compared to 17.4% in 2014. Novartis also focuses on acquisitions to sustain its strong presence in the market. For instance, in December 2016, Novartis acquired Ziarco Group Limited (U.K.), a privately held company focused on the development of novel treatments in dermatology. This acquisition strengthened Novartis’ dermatology portfolio and pipeline.

The overall growth strategies mapped from January 2013 to June 2017 include partnerships, agreements, collaborations, alliances, product launches and approvals, acquisitions, and expansions. Among these, product launches & product approvals and expansions were the key strategies adopted by industry players to achieve growth. Galderma S.A. (Switzerland), Valeant Pharmaceuticals International, Inc. (Canada), and Janssen Global Services LLC (U.S.) were some of the key players that adopted these strategies. 

For instance, in December 2016, Galderma S.A received approval from the U.S. Food and Drug Administration (FDA) to market Restylane Refyne and Restylane Defyne. Similarly, in September 2016, Crescita Therapeutics Inc. received approval for its Pliaglis topical anesthetic cream for commercial sale in Mexico. In November 2014, Valeant Pharmaceuticals received an approval from the U.S. Food and Drug Administration for ONEXTON Gel (clindamycin phosphate and benzoyl peroxide), used as a once-daily treatment of comedonal and inflammatory acne.

Target Audience

• Hospitals and Private Clinics
• Ambulatory Surgery Centers (ASCs)
• Academic Institutes
• Medical Research Institutes
• Market Research and Consulting Firms
• Venture Capitalists
• Suppliers and Distributors of Topical Products

Read more@

https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.html

Hospital Lighting - Major Industry Leaders & Different Strategies Adopted by Them to Retain Their Places in Global Market

The Hospital Lighting Market is consolidated in nature due to the presence of a few large players. The prominent players in the market include are General Electric Company (U.S.), Acuity Brands Lighting Inc. (U.S.), Cree Inc. (U.S.), Eaton Corporation PLC (Ireland), Hubbell Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), and Zumtobel Group AG (Austria). Other players in this market include Herbert Waldmann GmbH & Co. KG (Germany), KLS Martin Group (Germany), and Trilux Lighting Ltd (U.K.).

Koninklijke Philips N.V. (Netherlands) is the largest player in the global hospital lighting market. The company offers a wide range of products for hospital lighting. The company, with its strong product portfolio for hospital lighting has established itself as one of the leading players in this market.

The company focuses on product launches to strengthen its position in the market. For instance, in February 2017, Philips Lighting launched the Philips T5 LED tube. The T5 LED tube offers high light output and quality. In January 2017, Philips Lighting launched the Philips VL6000 Beam Luminaire. Philips VL6000 Beam offers a super bright output that exceeds 55,000 lumens. Such product launches enabled the company to maintain its dominance in this market.

Read More Details | Download the Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=207496480

General Electric Company (U.S.) is the second-largest player in the hospital lighting market. The company adopted product launches as its key strategy to strengthen its position in the market. For instance, in June 2015, GE launched the Bright Stik LED which is considered the replacement for CFL. GE is driving the adoption of LEDs with the introduction of Bright Stik.

Eaton Corporation PLC (Ireland) is the third-largest player in the global hospital lighting market. The company offers a wide range of lighting products used in various healthcare applications. The company focused on growing and improving the profitability of its businesses and implemented a strategy to launch hospital lighting specific products.

For instance, in August 2016, Eaton Corporation PLC launched Dim-to-Warm LED technology. LED products are offered in four-color temperatures including 2700K, 3000K, 3500K, and 4000K to satisfy the different needs of dwellings, hospitality, retail, office, and institutional spaces.

The key strategies followed by most companies in the hospital lighting market are product launches. The key players such as Acuity Brands Lighting Inc. (U.S.), Eaton Corporation PLC (Ireland), and Koninklijke Philips N.V. (Netherlands) are the leading manufacturing companies that adopted this strategy to expand their existing product portfolios and enhance their presence in the market.

Target Audience:

• Healthcare service providers (hospitals and surgical centers)
• Manufacturers of lighting Products
• Vendors and Distributors of Hospital Lightings
• Hospitals and clinics
• Research Institutes
• Venture Capitalists and Investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the hospital lighting market into the following segments:

Hospital lighting Market, by Product
# Troffers
# Surface-mounted Lights
# Surgical Lamps
# Other Products

Hospital lighting Market, by Technology
# Fluorescent
# LED
# Renewable Energy
# Other Technologies

Hospital lighting Market, by Application
# Patient Wards & ICUs
# Examination Rooms
# Surgical Suites
# Other Applications

Hospital lighting Market, by Region
# North America
# Europe
# Asia
# Rest of the World (RoW)

Read More@
https://www.marketsandmarkets.com/Market-Reports/hospital-lighting-market-207496480.html

Surgical Snare Market - Global Market Dynamics & Major Industry Leaders

                               Global Industry Overview

The Surgical Snare Market is expected to grow from USD 992 million in 2018 to USD 1,255 million by 2023, CAGR of 4.8% during the forecast period.

Major Industry Growth Drivers:    # Increasing Awareness on Colorectal Cancer Screening

# Growth of the Endoscopic Ambulatory Surgery Centers Segment

# Hospital Investments in Endoscopy Instruments

# Rising Patient Preference for Minimally Invasive Surgeries

Major Growth Restraint:

# Clinical Complications in Surgeries

Challenges:

# Dearth of Trained Physicians and Endoscopists

The study involved 4 major activities in estimating the current market size for surgical snares. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

You Can Also Request to Get the Sample Pages of this Report

Market Size Estimation:

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the surgical snares market. These approaches were also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

• The key players have been identified through extensive secondary research
• The surgical snares industry’s value chain and market size, in terms of value have been determined through primary and secondary research.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
• All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

North America is expected to account for the largest market share during the forecast period.

The surgical snare market is divided into four major regions North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share of this market, followed by Europe.

This is mainly attributed to the increasing prevalence of colon cancer and rising awareness of screening, diagnosis, and treatment procedures. The high incidence of colorectal cancer (CRC) in the US has resulted in the provision of reimbursements to increase the affordability of CRC screening procedures in the country. This has increased the affordability of CRC screening procedures, which in turn is driving the number of endoscopic procedures using the snaring technique performed in the US.

The major surgical snares vendors include Olympus (Japan), Boston Scientific (US), Cook Medical (US), CONMED Corporation (US), Medline Industries (US), Medtronic (Ireland), Steris (US), Merit Medical Systems (US), and Avalign Technologies (US).

Read More:
https://www.marketsandmarkets.com/Market-Reports/surgical-snare-market-109649493.html

Respiratory Care Devices Market by Type, Disease & End Users

The major factors driving the growth of this Respiratory Care Devices Market include high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes.

The rapid developments in emerging markets such as Asia-Pacific and Latin America and the growing demand for point-of-care (POC) diagnostic devices are expected to provide significant growth opportunities for players operating in the respiratory care devices market in the coming years. 

The rising demand for enhanced portable devices, growing demand for multimodal ventilators and focus of market players on expanding their geographic presence are the key trends of this market. However, the lack of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market.

Read More Details | Get the Sample Pages@ http://bit.ly/2A30Rsr

This market is segmented on the basis of type, disease/disorder, end user and regions. Based on type, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. The therapeutic devices segment is sub segmented into PAP devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods. The monitoring devices segment is sub segmented into pulse oximeters, capnographs and gas analyzers. 

The diagnostic devices segment is sub segmented into spirometers, polysomnography devices (PSG), peak flow meters and other diagnostic devices. The consumables and accessories segment is subsegmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas and other consumables and accessories. In 2015, therapeutic devices accounted for the largest share of the global respiratory care devices type market. The rising incidence of chronic diseases and growing geriatric population contributes to their largest share in respiratory care devices type market.

Based on disease/disorder, the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other diseases/disorders. The other diseases/disorders segment includes lung cancer, pulmonary fibrosis, pulmonary embolism, cystic fibrosis, and allergies. In 2015, COPD accounted for the largest share of the global respiratory care devices market, by disease/disorder. The factors contributing to the growth of this technology segment includes increasing tobacco smoking prevalence and rising pollution levels globally.

Furthermore, on the basis of end users, the market is classified into hospitals, home care and ambulatory care. The hospitals companies segment accounted for the largest share in the global respiratory care devices market, by end users. The factors contributing to the growth of this end user segment includes the financial capabilities of hospitals to purchase high-priced instruments as well as the availability of trained professionals in hospitals to operate respiratory care devices.

You Can Also Request to Get 10% FREE Customization on This Report

In 2015, North America accounted for the largest share of the global respiratory care devices market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the rising geriatric population, the presence of a well-established healthcare industry, availability of life sciences and medical research funding, rising geriatric population, growing demand for point-of-care diagnostic testing, and increasing government healthcare expenditure. 

As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. The rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, low labor costs, favorable regulatory environment and expansion of private-sector hospitals to rural areas in various APAC and Latin American countries are some factors that will fuel the growth of respiratory care devices market in these regions.

The global respiratory care devices market is fragmented, with the presence of many small and medium-size companies which operate in their respective market segments. In order to maintain their market shares, leading players in the market are continuously developing new technologies and upgrading their existing products to enhance their product portfolios. Some of the prominent players in the global market include Philips Healthcare (The Netherlands), ResMed Inc. (U.S.), Medtronic plc (Ireland), Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), Becton, Dickinson and Company (U.S.), Chart Industries, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).

Target Audience:

• Respiratory care device manufacturers and distributors
• Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
• Research institutes
• Contract manufacturing organizations (CMOs)
• Government associations
• Market research and consulting firms
• Venture capitalists and investors

Read More@ 

https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

Dental Lab Market: Major Leaders Focuses on Emerging Markets

Years considered for this report

• 2016 – Base Year
• 2017 – Estimated Year
• 2022 – Projected Year

Objectives of the Study

• To define, describe, and forecast the global dental laboratories devices market by material, equipment, prosthetic type, and region.
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
• To forecast the size of the dental laboratory market, in five main regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa
• To profile key players in the global dental laboratory market and comprehensively analyze their core competencies and market shares
• To track and analyze competitive developments such as research and development activities; joint ventures, alliances, mergers and acquisitions; new product/technology developments; and agreements, partnerships, and other developments of key players in the market

Download the PDF Brochure for more Details@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223694318

Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global dental laboratory market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. 

The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred to are the Canadian Dental Association, American Dental Association, British Dental Association, World Health Organization, Indian Dental Association, and Japan Dental Association.

Geographically, the global dental lab market is segmented into North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. Europe holds the largest share of this market. However, the APAC region is expected to witness the highest CAGR during the forecast period of 2017 to 2022

The growth of this segment can be attributed to the rising geriatric population, growing dental tourism, increase in the number of dental laboratories, and increasing outsourcing of various manufacturing services to the region are driving the growth of dental laboratories in APAC. However, the high cost of the dental equipment and materials is expected to hinder the growth of this market to a certain extent.

The global dental laboratory market is characterized by a large number of players. The prominent players in this market are DENTSPLY SIRONA Inc. (U.S.), Danaher Corporation (U.S.), 3M Company (U.S.), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Group (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Shofu Inc. (Japan), BEGO GmbH & Co. KG (Germany), VOCO GmbH (Germany), Ultradent Products, Inc. (U.S.), Septodont Holding (France), Planmeca Oy (Finland), and Kuraray Noritake Dental Inc. (Japan). These companies are pursuing several organic and inorganic growth strategies such as mergers, acquisitions, partnerships, agreements, expansions, and product launches to maintain their position in the market.

You Can Also Ask for 10% FREE Customization on This Report

Scope of the Report

The research report categorizes the global market into the following segments and sub segments:

Dental Lab Market By Indirect Restorative Materials

• Metal-ceramics
• Ceramics
  • Traditional All-ceramics
  • CAD/CAM Ceramics
    • Zirconia
    • Glass Ceramics
• Other Indirect Restorative Materials
  • Resins
  • Non-ceramics

Dental Lab Market By Equipment

• Milling Equipment
• Scanners
• Furnaces
• Articulators

Dental Lab Market By Prosthetic Type

• Bridges
• Crowns
  • Crowns & Bridges Materials
    • Porcelain Fused-to-Metal (PFM)
    • Traditional Ceramics
    • CAD/CAM Ceramics
    • Resins
    • Full Cast
• Dentures

Dental Lab Market By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• APAC
  • Japan
  • China
  • India
  • Australia
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Rest of Latin America
• Middle East and Africa

GE Healthcare (UK) and Siemens AG (Germany) are the Key Players in the Surgical Imaging Market

Agreements, collaborations, alliances, and partnerships were the key strategies adopted by players from 2014–2017. The players that adopted these strategies are Koninklijke Philips, Ziehm Imaging, GE Healthcare, Siemens, OrthoScan, Toshiba Medical Systems, and Medtronic. Koninklijke Philips accounted for a share of 38% of the total number of agreements, collaborations, alliances, and partnerships in the surgical imaging market. This high share of the company can be attributed to its increasing number of partnerships and collaborations with hospitals which are the primary end users of C-arms.

The global Surgical Imaging Market is projected to reach USD 1.63 Billion by 2022 from an estimated value of USD 1.25 Billion in 2017, at a CAGR of 5.5%. 

The surgical imaging market is emerging and fragmented in nature with various regional and international players. In 2016, the surgical imaging market was dominated by a few large players and several small players. 

Players in this market compete with each other to deliver superior quality products that are technologically advanced and to provide well-regulated customer service functions. Major companies in this market are GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany).

Talk to Our Research Experts for More Details on This Topic

GE Healthcare held the first position in the global surgical imaging market in 2016. Its leading position in the market is attributed to the highest number of installed systems and its wide and diverse platform of mobile C-arms. The company’s product portfolio of mobile C-arm includes OEC 9900 Elite, its flagship product. The OEC 9900 Elite provides improved image quality and optimal dose management which improves patient care. The product portfolio also includes OEC Brivio 865 Advance which was developed as an affordable option for orthopedic surgical imaging. The strong, wide, and diversified portfolio of mobile C-arms is an asset to the company.

Siemens acquired the second largest share of the global surgical imaging market in 2016. The company offers a comprehensive range of mobile C-arms. To maintain its leading position and increase its customer base in the surgical imaging market, the company mainly focuses on strategic partnerships with hospitals and other healthcare organizations. From 2014 to 2017, the company has partnered with many hospitals in the US, the UK, India, and Chile to offer its services and imaging systems.

Some of the other players competing in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), Allengers Medical Systems (India), and MS Westfalia (Russia).

Major Market Developments:

• In 2017, Koninklijke Philips partnered with Government of Kenya and the United Nations to Establish the SDG (Sustainable Development Goals) Partnership Platform in Kenya to make primary healthcare more accessible
• In 2017, Koninklijke Philips established its first innovation center in Moscow, Russia
• In 2017, Siemens Received US FDA approval for its Cios Fusion, Cios Connect, and Cios Select
• In 2017, Ziehm Imaging Launched the new version of Ziehm Vision FD with a complementary metal oxide semiconductor (CMOS) flat-panel detector and a new CMOS flat-panel detector which allows for display of smaller pixels in the same quality
• In 2016, Shimadzu Corporation established an indirectly-owned subsidiary—Shimadzu Malaysia Sdn Bhd.

The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

You Can Also Request Bundle Reports@ http://bit.ly/2BkzhGW

Target Audience:

• C-arms manufacturers and distributors
• Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
• Medical device vendors/service providers
• Research institutes
• Niche companies manufacturing imaging systems
• Research and consulting firms
• Venture capitalists

Report Scope:

Surgical Imaging Market, by Technology

• Image intensifier C-arms
• Flat Panel Detector C-arms (FPD C-arms)

Surgical Imaging Market, by Application

• Orthopedic and Trauma Surgeries
• Neurosurgeries
• Cardiovascular Surgeries
• Gastrointestinal Surgeries
• Other Applications (Urology and Endobronchial & Thoracic Surgery)

Surgical Imaging Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Rest of Europe (RoE)
• Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
• Rest of the World (RoW)

Read More: 
https://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html

Critical Questions Which the Report Answers:

What are new technology trends which the surgical imaging companies are exploring?

Which are the key players in the market and how intense is the competition?

Clinical Trial Management System Market - Competitive Scenario and Global Industry Trends

[266 Pages Report] The global Clinical Trial Management System Market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. 

This figure shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the overall demand for CTMS across key markets. 

However, budget constraints and limited awareness among researchers about the advantages of CTMS solutions are the major factors restraining the growth of CTMS market.

Market Dynamics:

Drivers:

# Significant partnerships between biopharma companies and CROs
# Rising number of clinical trials# Availability of advanced CTMS solutions
# Growing customer base for CTMS solutions# Rising government funding & grants to support clinical trials

Restraints:
# Budget constraints
# Limited awareness among researchers about the advantages of CTMS solutions

Opportunities:
# Increased outsourcing of clinical trial processes by industrial researchers to Asian countries/ developing countries CROs
# Increasing use of platform-as-a-service (PaaS) and mobile computing

Challenges:
# Lack of skilled professionals

Ask to Get the Discount on This Report@ 

https://www.marketsandmarkets.com/discountreports.asp?id=470

The following are the major objectives of the study.

# To define, describe, segment, and forecast the global CTMS market on the basis of components, type, delivery mode, end user, and region.

#To provide detailed information regarding the major factors influencing the overall market growth (drivers, restraints, opportunities, challenges, and trends) across individual geographies

#To analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the overall market

#To analyze growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

#To forecast the size of the market segments with respect to the four key regions—North America (US, Canada), Europe (Germany, UK, France, and RoE), Asia Pacific (China, Japan, India, and RoAPAC), and the Rest of the World (RoW)

#To profile the key players in the global CTMS market and comprehensively analyze their market shares and core competencies

#To track and analyze competitive developments such as product launches and product enhancements; agreements, partnerships, and collaborations; mergers and acquisitions; and R&D activities in the CTMS solutions market.

During this research study, major players operating in the CTMS market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size.

Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market.

You Can Also Request Bundle Reports@ 
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=470

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the CTMS market. Among these business strategies, product enhancements, agreements, and partnerships were the most widely adopted growth strategies by the players in the CTMS market.

Oracle (US) held the leading position in the global CTMS market in 2016. The company is one of the top players in the CTMS market due to its diversified geographic presence and large customer base, strong brand image, and selective and active acquisition program and alliances. The company offers cloud-based CTMS. The company has a strong geographic presence in over 175 countries across North America, Europe, Asia, Africa, and South America. The company mainly focuses on expansions and acquisitions to strengthen its dominant position in the market. For instance, in 2017, Oracle opened its Oracle Cloud EU Region in Germany, with the addition of modern infrastructure as a service (IaaS) architecture and new IaaS and platform as a service (PaaS) cloud services.

Medidata Solutions, Inc. (US) held the second position in the CTMS market in 2016. The company is one of the leading providers of cloud (software-as-a-service) solutions and has strong partnerships with CROs and pharmaceutical customers. Medidata is present in more than 130 countries with more than 849 customers across the globe. The company primarily adopts the strategy of partnerships to expand its presence in the CTMS market. In 2017, the company partnered with Karyopharm Therapeutics (US) to renew its Medidata Clinical Cloud platform.

Danaher (U.S.) Leads the Global Microscope Software Industry

The Microscope Software Market is projected to reach USD 780 million by 2023 from USD 414 million in 2018, at a CAGR of 13.5% during the forecast period. Market growth is largely driven by factors such as the rapid adoption of imaging solutions, the development of new microscopy methods, and increasing volumes of biological imaging data.

The major software vendors in this market include Danaher (US), Oxford Instruments (US), Zeiss (Germany), Olympus (Japan), Nikon (Japan), and Thermo Fisher Scientific (US). These players adopt various growth strategies such as expansions, acquisitions, and new product launches to expand their presence in the global microscope software market. Product launches and collaborations were the most widely adopted strategy by major players during 2015–2018. This helped them to expand their consumer base and address the unmet needs of end users.

Danaher (U.S.), a leading player in the Microscope software market, mainly focuses on developing innovative products for 3D/4D image visualization. The company offers an extensive product portfolio for this market through its subsidiaries, Molecular Devices and Leica Microsystems. It has a strong presence in more than 100 countries, including major markets such as the US, China, Germany, and Japan. 

Ask to Get the Discount on This Report@ 

https://www.marketsandmarkets.com/discountreports.asp?id=89006739

Danaher focuses on inorganic growth strategies such as partnerships and collaborations to remain competitive in the market. In 2018, it collaborated with several companies such as Triolab AS (Denmark) and Thermo Fisher Scientific (US) as well as institutions such as the University of California, Los Angeles (US) and King Abdullah University of Saudi Arabia (Saudi Arabia).

Zeiss is another leading company that provides microscopes and software. Its software product range covers electron, confocal, as well as correlative microscopy. The company’s Zen software for light and confocal microscopy is well-established and widely used in life sciences research. Carl Zeiss focuses on inorganic growth strategies such as collaborations and partnerships. 

In 2017, the company entered into a collaboration with VB Bioimaging Center (Belgium) to develop and patent an innovative software-based super-resolution image processing technology. The company has a vast geographic presence and operates in 150 countries across the world. Carl Zeiss has a strong portfolio that provides it with a competitive advantage in the market.

North America is expected to account for the largest market share during the forecast period.

North America is the major revenue-generating region in the global microscope software market. Factors such as the strong life sciences industry and a large base of academic and research institutes in the US are driving the growth in this region. Similarly, Canada is also a potential market for microscopy owing to favorable government support and the growing academic excellence in nanotechnology-based R&D programs.

Key Market Players:

The major microscope software vendors include Danaher (US), Oxford Instruments (US), Carl Zeiss (Germany), Olympus (Japan), Nikon (Japan), and Thermo Fisher Scientific (US). Danaher is the leading player in the market. The company has the broadest portfolio in the market since two of its subsidiaries—Molecular Devices and Leica Microsystems—are leaders in the microscopy business. These two companies’ combined have 14 microscopy software products on the market.

Oxford Instruments serves end users in various industries such as life sciences, astronomy, and physical sciences through its two subsidiaries—Andor Technology and Bitplane. The company offers products for image acquisition, 3D visualization, and analysis, as well as software development kits, deconvolution software, and image-stitcher software. Due to its broad portfolio and established customer base, Oxford Technology holds a strong position in the market.

You Can Also Request Bundle Reports@
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=89006739Recent Developments:

• In 2018, DRVISION technologies partnered with Etaluma systems to provide Aivia image analysis solutions with Etaluma’s microscope systems.
• In 2017, Carl Zeiss collaborated with VIB Bioimaging Core to develop and patent an innovative software-based super-resolution image processing technology.
• In 2017, Carl Zeiss partnered with Glencoe software to extend the open-source Bio-Formats image file conversion library to support whole-slide images compressed with the JPEG XR compression scheme.

Key Questions Addressed by the Report:

• Who are the major players in the microscope software market?
• What are the growth trends and the largest revenue-generating regions for microscope software?
• How are microscope software sold to customers?
• What are the major types of microscope software?
• Who are the major end users of microscope software in the life sciences industry?

Dermatology Devices Market: Upcoming Trends | Emerging Economies | Global Future Forecasts | Challenges & Opportunities

Rising incidence of skin disorders and technological advancements in medical imaging devices are to drive the market in 2016

The global dermatology devices market is segmented into diagnostic devices (by type and application) and treatment devices (by type and application). Based on the type of diagnostic devices, the dermatology devices market is segmented into dermatoscopes, microscopes, and imaging devices. The imaging devices segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to technological advancements and increasing awareness about the available aesthetic procedures in the market.

Rising incidence of skin disorders, technological advancements, increasing preference for minimally invasive surgeries, and increasing awareness about aesthetic procedures are the major factors driving the growth of light therapy devices market

On the basis of the type of treatment devices, the dermatology devices market is segmented into light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion devices, and cryotherapy devices. In 2016, the light therapy devices segment is expected to account for the largest share primarily due to the increasing incidence of skin diseases and technological advancements.

Ask for the Discount on This Report@ 
https://www.marketsandmarkets.com/discountreports.asp?id=154

Skin cancer diagnosis is expected to account for the largest share of the dermatology diagnostic devices applications market in 2016

On the basis of the application of diagnostic devices, the dermatology devices market is segmented into skin cancer diagnosis and other diagnostic applications. The skin cancer diagnosis segment is expected to account for the largest share in 2016. The rising incidence of skin disorders is the major factor driving the growth of this market.

Other treatment application is expected to account for the largest share of the dermatology treatment devices applications market in 2016

On the basis of the application of treatment devices, the dermatology devices market is segmented into hair removal; skin rejuvenation; acne, psoriasis, and tattoo removal; wrinkle removal and skin resurfacing; body contouring and fat removal; vascular and pigmented lesion removal; warts, skin tags, and weight management; and other treatment applications. The other treatment applications segment is expected to account for the largest share of the market during the forecast period, primarily due to the increasing awareness about aesthetic procedures and technological advancements.

Asian region is projected to register the highest CAGR during the forecast period

Based on region, the global dermatology devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Growth in this regional segment is driven by factors such as the rising incidence of skin diseases, increasing healthcare expenditure, and increasing awareness regarding aesthetic procedures.

Some of the major players operating in the dermatology devices market are Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis, Ltd. (Israel), and Valeant Pharmaceuticals International, Inc. (Canada).

You Can Also Request the Bundle Reports@ 
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=154

Study Coverage:

The report segments this market by diagnostic devices, treatment devices, diagnostic devices application, treatment devices application and region. The study covers the global Dermatology Devices market from 2016 to 2021 and provides details of the factors influencing the market at both the macro- and micro-level along with competitive developments and recent market trends. The report provides a detailed overview of the major drivers, opportunities, current market challenges, and strategies impacting this market along with the estimates and forecasts of the revenue and market share analysis.